HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Gelatinol

8% gelatin solution containing various salts.

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Scleroproteins: 74
    - Gelatin: 4201
      - Gelatinol: 8

Related Diseases

1.	Hypercalcemia (Milk Alkali Syndrome) 01/01/1996 - "Examinations of the patients have shown that "Modegel" unlike "Gelatinol" does not induce hypercalcemia and hyperosmolarity of plasma while moderate hyperoncoticity of plasma is responsible for the circulating blood volume and favorable conditions for microcirculation." 05/01/1991 - "A decrease in gelatinol volume to 450-600 ml prevented the onset of marked hypercalcemia. " 07/01/1989 - "The use of considerable amounts of gelatinol in hypothermal perfusion determined the occurrence of marked hypercalcemia. "
2.	Chronic Bronchitis 01/01/1985 - "The authors present some theoretical and experimental prerequisites for differentiated use of hemodez, rheopolyglucin and gelatinol in asthma, chronic bronchitis and pneumonia. "
3.	Pneumonia (Pneumonitis) 01/01/1985 - "The authors present some theoretical and experimental prerequisites for differentiated use of hemodez, rheopolyglucin and gelatinol in asthma, chronic bronchitis and pneumonia. "
4.	Hypertrophy 03/01/1983 - "Renal perfusion with Tyrode solution to which gelatinol was added revealed gradual development of structural changes in renal vessels as arterial hypertension was developing and stabilizing in spontaneously hypertensive rats, as evidenced by shifts in "perfusion pressure--perfusion rate" and "glomerular filtration rate--perfusion pressure" curves, increased afferent/efferent arteriole resistance ratio and enhanced renal vascular response to angiotensin II due to hypertrophy and reduced inner radius of smooth-muscle afferent arterioles. "
5.	Hypertension (High Blood Pressure) 03/01/1983 - "Renal perfusion with Tyrode solution to which gelatinol was added revealed gradual development of structural changes in renal vessels as arterial hypertension was developing and stabilizing in spontaneously hypertensive rats, as evidenced by shifts in "perfusion pressure--perfusion rate" and "glomerular filtration rate--perfusion pressure" curves, increased afferent/efferent arteriole resistance ratio and enhanced renal vascular response to angiotensin II due to hypertrophy and reduced inner radius of smooth-muscle afferent arterioles. "

Related Drugs and Biologics

1.	Solutions
2.	Dextrans (Dextran)
3.	Angiotensin II

Related Therapies and Procedures

1.	Intravenous Administration